CompletedNot Applicable

Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)

Singapore72 participantsStarted 2019-07-05

Plain-language summary

To determine long-term outcomes, recurrence rates, and treatment needs in Polypoidal Choroidal Vasculopathy (PCV). Specifically, to describe the long-term outcomes, recurrence rates and treatment patterns PCV patients 5 years after first presentation. This study will also evaluate whether polyp closure within the first 12 months of therapy is associated with better long-term visual outcome and will also determine the risk of disease development in the fellow eye

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants will have completed the previous PCV RCTs: EVEREST II, PLANET and PCV T\&E studies * Are able to give consent for this follow up study Exclusion Criteria: * No exclusion criteria unless they do not meet the inclusion criteria

What they're measuring

Long term prognostication

Timeframe: within 72 months

Trial details

NCT IDNCT03929731

SponsorSingapore National Eye Centre

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2024-05-09

View on ClinicalTrials.gov More Polypoidal Choroidal Vasculopathy trials